Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. . (2024). Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ Open, 14, e072361. http://doi.org/10.1136/bmjopen-2023-072361
Drug Therapy, Combination
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975–1986. http://doi.org/10.2147/copd.s378486
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480
Rebordosa, C. ., Plana, E. ., Rubino, A. ., Aguado, J. ., Martinez, D. ., Lei, A. ., … Rivero-Ferrer, E. . (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715–1733. http://doi.org/10.2147/copd.s363997
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133–141. http://doi.org/10.1080/15412555.2022.2045265